ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,231, issued on Dec. 2, was assigned to University of Pittsburgh-Of the Commonwealth System of Higher Education (Pittsburgh).
"Targeted nitroxide compounds and their use in treating ferroptosis-related diseases" was invented by Peter Wipf (Pittsburgh), Taber Sarah Maskrey (Pittsburgh), Matthew G. LaPorte (Seven Fields, Pa.) and Manwika Charaschanya (San Diego).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds useful in the prevention or treatment of ferroptosis in a patient, and methods of preventing or treating ferroptosis, or a treating a condition or disease associated with ferroptosis, such as a patient having a neurodege...